Huang et al., (2014) reported a close association between SOX2 expression with clinicopathological parameters in breast cancer; including high histological grade, large tumor size, molecular subtypes, negative hormone receptor status and high proliferation index. The gene discussed is NR4A1; the disease is breast carcinoma.